BOT 1.33% 38.0¢ botanix pharmaceuticals ltd

Risk at this point is: 1) Poor market penetration. We won’t see...

  1. 10 Posts.
    lightbulb Created with Sketch. 2
    Risk at this point is:

    1) Poor market penetration. We won’t see this outcome to Q4.

    2) Poor repeat purchase. I’d say this is a customer sentiment issue. I.E is the cost worth the benefit, does it last longer than anticipated. Could be that people only buy once as they work out they don’t have life changing outcomes when the issue goes away for a month or two.

    3) Profitability. If customer acquisition costs end up being astronomical this could be an issue.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
38.0¢
Change
0.005(1.33%)
Mkt cap ! $594.6M
Open High Low Value Volume
37.0¢ 38.0¢ 35.5¢ $3.684M 10.03M

Buyers (Bids)

No. Vol. Price($)
5 67146 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
38.0¢ 561052 18
View Market Depth
Last trade - 14.04pm 25/06/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.